Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AWESOME: Aliskiren/Amlodipine in Hypertension
NCT01113047Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in essential hypertension, sponsored by Novartis. Started May 2010; status: completed.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01113047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113047.